Formulation, Characterization and Antioxidant Myricetin Nanophytosome for Topical Delivery
Background: Phytosomes are recently introduced drug delivery system and novel botanical formulation to produce lipophilic molecular complex to improve absorption and bioavailability of phytoconstituent. Myricetin is a well-known flavonoid with different biological effects and contributed in food preserving by free radical scavenging activity. However, bioavailability of myricetin is an important limiting factor for its antioxidant activities.
Purpose: To overcome this limitation, in the present study we aimed to produce myricetin-loaded nano phytosomes to improve its physicochemical stability and bioavailability.
Methods: myricetin-loaded nano phytosome was prepared by using phosphatidylcholine (PC) and cholesterol (CH). Myricetin nanophytosomes system was characterized by particle size analyzer, particle size distribution (PDI), encapsulation efficiency and potential antioxidant activity.
Results: Results showed that formulation with the myricetin: PC: CH molar ratio of 1: 2: 0.8 had lower particle size (291.11 nm) and higher encapsulation efficiency percent (93%). Morphology analysis showed that myricetin nanophytosome spherical shape. The potential antioxidant data showed that incorporation myricetin in the phospholipid myricetin remained unchanged even after encapsulation of myricetin in binarynanophytosome formulation.
Conclusion: Nano phytosomal formulation of myricetin showed promising potential in fortification of nutraceutical with water insoluble antioxidants.
2. Gacche RN. Shegokar. HD. Gond DS. Yang Z. Jadhav AD. Evaluation of selected flavonoids as antiangiogenic, anticancer, and radical scavenging agents: an experimental and in silico analysis. Cell Biochem Biophys.2011; 61:651–663.
3. Sindhi V. Gupta V. Sharma K. Bhatnagar S. Kumari R. Dhaka N. Potential applications of antioxidants- a review. Journal of Pharmacy Research.2013; 7:828-835.
4. Leonarduzzi G. Testa G. Sottero B. Gamba P and Poli G. Design and development of nano vehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids. Current Medicinal Chemistry. 2010; 17:74-95.
5. OdehF.Al-JaberH and KhaterD.Application of nanotechnology in drug delivery. New York: InTech; 2014:344-368.
6. ProcházkováD.BoušováI.WilhelmováN. Antioxidant and prooxidant properties of flavonoids. Fitoterapia. 2011; 82:513–523
7. Hu-JunX.Wang-ShuM.Fu-RongL.Jie-HuiX. Lei. Qun-FangL.Wen-JunF.Radical scavenging activity of fisetin, Acta Phys. -Chim. Sin.2013; 29(7):1421-1432.
8. Hong C. Dang Y. Lin G. YaoY. LiG. Ji G. Shen H. XieY. Effects of stabilizingagents on the development of myricetinnanosuspension and its characterization: an in vitro and in vivo evaluation, International Journal of Pharmaceutics.2014; 477:251–260.
9. Guzzo MR.Semi M.Donate PM. Nikolaou S.Antonio Eduardo H. Machado AEH.Okano LTA. Study of the complexation of fisetin with cyclodextrins. Journal PhysChem.2006;110 (36):10545-1055.
10. Sowa M. Slepokura K. Matczak -Jon E. Improving solubility of fisetin by cocrystallization. CrysEngCom. 2014; 16:10592-10601.
11. Seguin J. Brulle L. Boyer R. Lu YM. Ramos Romano M. Touil YS. Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy. International journal of pharmaceutics. 2013; 444(1-2):146-54.
12. Wang L. Zhang DZ. Wang YX. Bioflavonoid fisetin loaded alpha-tocopherol-poly(lactic acid)-based polymeric micelles for enhanced anticancer efficacy in breast cancers. Pharmaceutical Research. 2017; 34(2):453-61.
13. Bothiraja C. Yojana BD, Pawar AP. Shaikh KS and Thorat UH. Fisetin-loadednanocochleates: formulation and
14. Characterization, in vitro anticancer testing, bioavailability and biodistribution study. Expert Opin. Drug Deliv. 2014; 11(1):17-29.
15. Al-Kassas R. Bansal M. Shaw J.Nanosizing techniques for improving bioavailability of drugs. Journal Control Release. 2017; 260:202 – 2012.
16. Junghanns AH and Müller RH. Nanocrystal technology, drug delivery and clinical applications. International Journal of Nanomedicines. 2008; 3(3):295-309.
17. KeckCM. and MullerRH. Drug nanocrystal of poorly soluble drugs produced by high-pressure homogenization. Eur J Pharm Biopharm. 2008; 62(1)3-16.
18. Sinha B. Muller RH. Moschwitzer JP. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. Int J Pharm. 2013;453(1):126-141.
19. Junyaprasert VB. and MorakulB. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian Journal of Pharmaceutical Science. 2015; 10:10-23.
20. De Waard H. Frijlink HW. Hinrichs WLJ. Bottom-up preparation techniques for nanocrystals of lipophilic drugs. Pharmaceutical Research. 2011; 28(5):1220-1223.
21. Möschwitzer JP. Drug nanocrystals in the commercial pharmaceutical development process. International Journal of Pharmaceutics. 2013; 453(1):142-156.
22. Rautenbach F, Venter I. Hydrophilic and lipophilic antioxidant capacity of commonly consumed South African fruits, vegetables, grains, legumes, fats/oils and beverages. J Food Compost Anal 2010; 23:753761.
23. Santos NW, Santos GTD, Silva-Kazama DC, Grande PA, Pintro PM, De Marchi FE, et al. Production, composition and antioxidants in milk of dairy cows fed diets containing soybean oil and grape residue silage. Livest Sci 2014;159:37-45
24. Contini C, Álvarez R, O'sullivan M, Dowling DP, Gargan SÓ, Monahan FJ. Effect of an active packaging with citrus extract on lipid oxidation and sensory quality of cooked turkey meat. Meat Sci 2014; 96:1171-1176.
25. Kerry JP. 20 - Application of smart packaging systems for conventionally packaged muscle-based food products. In: Kerry JP, editor. Advances in Meat, Poultry and Seafood Packaging: Woodhead Publ 2012. p.522-564.
26. Mahajan T, M C. A novel approach towards phytosomal flavonoids. Pharma Sci 2012; 4:20792121.
27. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983; 32:1141-1148.
28. Hollman PCH, Trijp JMP, Buysman M, Gaag M, Mengelers M, Vries J, et al. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 1997; 418:152-156.
29. Guardia T, Rotelli AE, Juarez AO, Pelzer LE. Antiinflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Il Farmaco 2001; 56:683-687.
30. Wang L, Wang B, Li H, Lu H, Qiu F, Xiong L, et al. Quercetin, a flavonoid with anti-inflammatory activity, suppresses the development of abdominal aortic aneurysms in mice. Eur J Pharmacol 2012; 690:133-141.
31. Bose S, Michniak-Kohn B. Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. Eur J Pharm Sci 2013; 48:442-452
32. Li H, Zhao X, Ma Y, Zhai G, Li L, Lou H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Controlled Release 2009; 133:238-244.
33. Liu D, Hu H, Lin Z, Chen D, Zhu Y, Hou S, et al. Quercetin deformable liposome: Preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivo. J Photochem Photobiol B: Biology 2013; 127:8-17
34. Xie Y, Luo H, Duan J, Hong C, Ma P, Li G, et al. Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L. Fitoterapia 2014; 93:216-225.
35. Yang B, Chen F, Hua Y, Huang S-S, Lin S, Wen L, et al. Prooxidant activities of quercetin, p-courmaric acid and their derivatives analysed by quantitative structure–activity relationship. Food Chem 2012; 131:508-512.
36. Pandey R, Ahmad Z, Sharma S, Khuller GK. Nanoencapsulation of azole antifungals: Potential applications to improve oral drug delivery. Int J Pharm 2005; 301:268-276.
37. Dian L, Yang Z, Li F, Wang Z, Pan X, Peng X, et al. Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study. Int J Nanomed 2013;8:845-854
38. Guo L, Hamilton R, Goerke J, Weinstein J. Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins. J Lipid Res 1980; 20:993-1003.
39. Vandijk C, Driessen A, Recourt K. The uncoupling efficiency and affinity of flavonoids for vesicles. Biochem Pharmacol 2000; 60:1593-1600.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).